Aquatic Capital Management’s ANI Pharmaceuticals ANIP Stock Holding History

Aquatic Capital Management’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$522K	Buy	+6,309	New	+$506K	0.02%	778
2025 Q4	–	Sell	-12,574	Closed	-$1.15M	–	1385
2025 Q3	$1.15M	Buy	+12,574	New	+$1.03M	0.02%	621
2025 Q2	–	Sell	-13,224	Closed	-$885K	–	1229
2025 Q1	$885K	Buy	13,224 +6,484	+96%	+$387K	0.02%	631
2024 Q4	$373K	Buy	6,740 +4,040	+150%	+$232K	0.01%	790
2024 Q3	$161K	Buy	2,700 +1,800	+200%	+$110K	﹤0.01%	862
2024 Q2	$57.3K	Buy	+900	New	+$58.4K	﹤0.01%	991
2024 Q1	–	Sell	-6,000	Closed	-$331K	–	1202
2023 Q4	$331K	Buy	+6,000	New	+$330K	0.01%	732
2023 Q2	–	Sell	-700	Closed	-$28K	–	1308
2023 Q1	$28K	Buy	+700	New	+$29.5K	﹤0.01%	990
2022 Q4	–	Sell	-1,100	Closed	-$35K	–	1337
2022 Q3	$35K	Buy	+1,100	New	+$37.7K	﹤0.01%	933

Other funds holding ANIP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

GACM

Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Aquatic Capital Management's ANIP Position: Q2 2026 in Review

Aquatic Capital Management opened a new position in ANI Pharmaceuticals (ANIP) in Q2 2026: 6,309 shares worth $522K. The stake represents 0.02% of the portfolio and ranks #778 among its holdings. This is a return to the name: Aquatic Capital Management previously reported a position in ANIP as recently as Q3 2025.

Aquatic Capital Management first reported a position in ANIP in Q3 2022 and has held it in 9 quarters since. The position peaked at $1.15M in Q3 2025. 307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

Aquatic Capital Management held 6,309 shares of ANI Pharmaceuticals worth $522K as of Q2 2026.
ANI Pharmaceuticals was a new Aquatic Capital Management position in Q2 2026.
ANI Pharmaceuticals made up 0.02% of Aquatic Capital Management's portfolio in Q2 2026, its #778 holding.
Aquatic Capital Management first reported a position in ANI Pharmaceuticals in Q3 2022 and has held it in 9 quarters since.
Aquatic Capital Management's ANI Pharmaceuticals position peaked at $1.15M in Q3 2025.
307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Aquatic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.